Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 6/20 | 0.50 |
| ▸ | CA1 | P00915 | 6/20 | 0.50 |
| ▸ | CA2 | P00918 | 6/20 | 0.50 |
| ▸ | CA7 | P43166 | 6/20 | 0.50 |
| ▸ | CA9 | Q16790 | 6/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 6/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.42 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.42 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.41 |
| ▸ | JMJD6 | Q6NYC1 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6950001 | 0.80 | CA12 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6134999 | 0.79 | CA12 (0.51) | CA12CA1CA2CA7CA9 | |
| SCHEMBL129051 | 0.73 | CA12 (0.62) | CA12CA1CA2CA7CA9 | |
| SCHEMBL676545 | 0.73 | ALDH1A1 (0.40) | HTTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL15474744 | 0.72 | ICAM1 (0.36) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8772807 | 0.72 | CA12 (0.44) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1817014 | 0.72 | CA12 (0.60) | CA12CA1CA2CA7CA9 | |
| SCHEMBL43683 | 0.71 | NPC1 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL701832 | 0.70 | CA12 (0.83) | CA12CA1CA2CA7CA9 | |
| SCHEMBL16606258 | 0.70 | CA12 (0.75) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8703202-B2 | Coated tablets | JAGOTEC AG (CH) | 2014-04-22 | — | — | US | disclosed |
| EP-1276465-B1 | IMPROVED WATER-INSOLUBLE DRUG PARTICLE PROCESS | JAGOTEC AG (CH) | 2014-03-12 | — | — | EP | disclosed |
| US-8586094-B2 | Coated tablets | JAGOTEC AG (CH) | 2013-11-19 | — | — | US | disclosed |
| US-20120064160-A1 | Fibrate-statin Combinations with Reduced Fed-fasted Effects | JAGOTEC AG (CH) | 2012-03-15 | — | — | US | disclosed |
| EP-1320362-B1 | STABILISED FIBRATE MICROPARTICLES | JAGOTEC AG (CH) | 2011-08-31 | — | — | EP | disclosed |
| EP-2228060-A1 | Oral dosage forms comprising fenofibrate | SKYEPHARMA CANADA INC. (CA) | 2010-09-15 | — | — | EP | disclosed |
| EP-1796625-A4 | NOVEL FENOFIBRATE FORMULATIONS AND RELATED METHODS OF TREATMENT | TRANSFORM PHARMACEUTICALS INC (US) | 2009-07-15 | — | — | EP | disclosed |
| US-20090149533-A1 | NOVEL FENOFIBRATE FORMULATIONS AND RELATED METHODS OF TREATMENT | TRANSFORM PHARMACEUTICALS, INC. (US) | 2009-06-11 | — | — | US | disclosed |
| EP-1322289-B1 | SPRAY DRYING PROCESS OF COMPOSITIONS CONTAINING FENOFIBRATE | JAGOTEC AG (CH) | 2007-07-25 | — | — | EP | disclosed |
| EP-1796625-A2 | NOVEL FENOFIBRATE FORMULATIONS AND RELATED METHODS OF TREATMENT | Transform Pharmaceuticals, Inc. (US) | 2007-06-20 | — | — | EP | disclosed |
| US-6534088-B2 | Dosage form of a statin and microparticles of fenofibrate stabilized by a phospholipid surface active substrance; bioavailability unaffected by food intake | SKYEPHARMA CANADA INC. (CA) | 2003-03-18 | — | — | US | disclosed |
| EP-1276465-A2 | IMPROVED WATER-INSOLUBLE DRUG PARTICLE PROCESS | RTP Pharma Inc. (US) | 2003-01-22 | — | — | EP | disclosed |
| US-20020161032-A1 | Fibrate-statin combinations with reduced fed-fasted effects | SKYEPHARMA AG (CH) | 2002-10-31 | — | — | US | disclosed |
| WO-2002067901-A1 | FIBRATE-STATIN COMBINATIONS WITH REDUCED FED-FASTED EFFECTS | SKYEPHARMA CANADA INC. (CA) | 2002-09-06 | — | — | WO | disclosed |
| US-20020058065-A1 | Insoluble drug particle compositions with improved fasted-fed effects | JAGO RESEARCH AG (CH) | 2002-05-16 | — | — | US | disclosed |
| US-20020056206-A1 | Spray drying process and compositions of fenofibrate | RTP PHARMA INC. (CA) | 2002-05-16 | — | — | US | disclosed |
| WO-2002024169-A1 | SPRAY DRYING PROCESS AND COMPOSITIONS OF FENOFIBRATE | SKYEPHARMA CANADA INC. (CA) | 2002-03-28 | — | — | WO | disclosed |
| WO-2002024193-A1 | STABILISED FIBRATE MICROPARTICLES | SKYEPHARMA CANADA INC. (CA) | 2002-03-28 | — | — | WO | disclosed |
| US-20020012704-A1 | Water-insoluble drug particle process | JAGO RESEARCH AG (CH) | 2002-01-31 | — | — | US | disclosed |
| WO-2001080828-A2 | IMPROVED WATER-INSOLUBLE DRUG PARTICLE PROCESS | RTP PHARMA INC. (US) | 2001-11-01 | — | — | WO | disclosed |